Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027

Cencora executives expect its specialty-focused strategy to sustain growth through fiscal 2027, supported by demand in oncology and retina markets. The company also cited expanded physician-services capabilities as a growth driver, signaling confidence in its longer-term specialty-pharmaceutical distribution outlook.